1-2 of 2
Johannes Elferich, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pacritinib Targets IRAK1 and Shows Synergy with HDAC and BET Inhibitors in Acute Myeloid Leukemia

Alka Puri, PhD, Shawn Mahmood, B.S., B.A., Bernadette Maertens, Monika Davare, PhD, Stephen E Kurtz, PhD, Cristina E. Tognon, Christopher O. Eden, BA, Johannes Elferich, PhD, Ujwal Shinde, PhD, Brian J. Druker, MD, Jack W. Singer, Anupriya Agarwal
Journal: Blood
Blood (2016) 128 (22): 3514.
https://doi.org/10.1182/blood.V128.22.3514.3514
Published: 2016
Journal Articles

Pacritinib, a Dual FLT3/JAK2 Inhibitor, Reduces Irak-1 Signaling in Acute Myeloid Leukemia

Megan M Cleary, B.S., B.A., Rhese Thompson, Shawn Mahmood, B.S., B.A., Monika Davare, PhD, Steve Kurtz, PhD, Johannes Elferich, PhD, Ujwal Shinde, PhD, Brian J. Druker, MD, Jack Singer, MD, Anupriya Agarwal, PhD
Journal: Blood
Blood (2015) 126 (23): 570.
https://doi.org/10.1182/blood.V126.23.570.570
Published: 2015